Tumor angiogenesis as a prognostic assay for invasive ductal breast carcinoma

Journal of the National Cancer Institute

Volumn 87, Issue 13, 1995, Pages 997-1008

  Axelsson, Karen ^a   Ljung, Britt Marie E ^a   Moore, Dan H ^c   Thor, Ann D ^d   Chew, Karen L ^b   Edgerton, Susan M ^d   Smith, Helene S ^c   Mayall, Brian H ^b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c CALIFORNIA PACIFIC MEDICAL CENTER   (United States)

^d UNIVERSITY OF VERMONT   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD CLOTTING FACTOR 8; ESTROGEN; ESTROGEN RECEPTOR; PROTEIN P53;

ANGIOGENESIS; ARTICLE; BREAST CARCINOMA; CANCER GRADING; CONTROLLED STUDY; HISTOCHEMISTRY; HUMAN; HUMAN TISSUE; IMMUNOCYTOCHEMISTRY; MAJOR CLINICAL STUDY; METASTASIS; MICROSCOPY; PREDICTION; PROGNOSIS;

ANALYSIS OF VARIANCE; BREAST NEOPLASMS; CARCINOMA, INFILTRATING DUCT; FACTOR VIII; HUMAN; IMMUNOHISTOCHEMISTRY; LYMPHATIC METASTASIS; MIDDLE AGE; NEOVASCULARIZATION, PATHOLOGIC; OBSERVER VARIATION; PREDICTIVE VALUE OF TESTS; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; PROTEIN P53; RETROSPECTIVE STUDIES; SINGLE-BLIND METHOD; SUPPORT, U.S. GOV'T, P.H.S.; SURVIVAL ANALYSIS;

EID: 0029010325     PISSN: 00278874     EISSN: None     Source Type: Journal    
DOI: 10.1093/jnci/87.13.997     Document Type: Article

References (41)

1. Miller BA, Feuer EJ, Hankey BP: The increasing incidence of breast cancer since 1982: relevance of early detection. Cancer Causes Control 2:6774, 1991
2. Harris JR, Heilman S: Natural history of breast cancer. In Breast Diseases (Harris JR, Heilman S, Henderson IC, et al, eds). Philadelphia: Lippincott, 1991, pp 165-181
3. Harris JR, Henderson IC: Staging and prognostic factors. In Breast Diseases (Harris JR, Heilman S, Henderson IC, et al, eds). Philadelphia: Lippincott, 1991, pp 327-346
4. Gasparini G, Pozza F, Harris AL: Evaluating the potential usefulness of new prognostic and predictive indicators in node-negative breast cancer patients [published erratum appears in J Natl Cancer Inst 85:1605, 1993]. J Natl Cancer Inst 85:1206-1219,1993
5. Thor AD, Schwartz LH, Koemer FC, et al: Analysis of c-erbB-2 expression in breast carcinomas with clinical follow-up. Cancer Res 49:7147-7152,1989
6. Muss HB, Thor AD, Berry DA, et al: c-erbB-2 expression and response to adjuvant therapy in women with node-positive early breast cancer [see comment citation in Medline]. N Engl J Med 330:1260-1266, 1994.
7. Thor AD, Moore DH O, Edgerton SM, et al: Accumulation of p53 tumor suppressor gene protein: an independent marker of prognosis in breast cancers. J Natl Cancer Inst 84:845-855, 1992
8. Folkman J: What is the evidence that tumors are angiogenesis dependent [editorial]? J Natl Cancer Inst 82:4-6, 1990
9. Srivastava A, Laidler P, Davies RP, et al: The prognostic significance of tumor vascularity in intermediate thickness (0.76-4.0 mm thick) skin melanoma. Am J Pathol 133:419-423,1986
10. Weidner N: Tumor angiogenesis: review of current applications in tumor prognostication. Semin Diagn Pathol 10:302-313, 1993.
11. Gasparini G, Harris AL: Clinical importance of the determination of tumor angiogenesis in breast carcinoma: much more than a new prognostic tool. J Clin Oncol 13:765-782,1995
12. Weidner N, Semple JP, Welch WR, et al: Tumor angiogenesis and metastasis—correlation in invasive breast carcinoma. N Engl J Med 324:1-8, 1991
13. Weidner N, Folkman J, Pozza F, et al: Tumor angiogenesis: a new significant and independent prognostic indicator in early-stage breast carcinoma [see comment citations in Medline]. J Natl Cancer Inst 84:1875-1887,1992
14. Page DL, Dupont WD: Breast cancer angio-histogenesis: through a narrow window [editorial] [see comment citation in Medline]. J Natl Cancer Inst84:1850-1851,1992
15. Gasparini G, Weidner N, Bevilacqua P, et al: Tumor microvessel density, p53 expression, tumor size, and peritumoral lymphatic vessel invasion are relevant prognostic markers in node-negative breast carcinoma [see comment citation in Medline]. J Clin Oncol 12:454-466,1994.
16. Folkman J: Angiogenesis and breast cancer [editorial] [see comment citation in Medline]. J Clin Oncol 12:441-443,1994
17. Bosari S, Lee AK, DeLellis RA, et al: Microvessel quantitation and prognosis in invasive breast carcinoma. Hum Pathol 23:755-761, 1992.
18. Fox SB, Leek RD, Smith K, et al: Tumor angiogenesis in node-negative breast carcinomas—relationship with epidermal growth factor receptor, estrogen receptor, and survival. Breast Cancer Res Treat 29:109-116, 1994.
19. Hall NR, Fish DE, Hunt N, et al: Is the relationship between angiogenesis and metastasis in breast cancer real? Surg Oncol 1:223-229,1992.
20. Horak ER, Leek R, Klenk N, et al: Angiogenesis, assessed by platelet/en-dothelial cell adhesion molecule antibodies, as indicator of node metas-tases and survival in breast cancer. Lancet 340:1120-1124,1992.
21. Horak ER, Harris AL, Stuart N, et al: Angiogenesis in breast cancer. Regulation, prognostic aspects, and implications for novel treatment strategies. Ann N Y Acad Sci 698:71-84, 1993
22. Obermair A, Czerwenka K, Kurz C, et al: Influence of tumoral microvessel density on the recurrence-free survival in human breast cancer: preliminary results. Onkologie 17:44-49,1994
23. Toi M, Kashitarti J, Tominaga T: Tumor angiogenesis is an independent prognostic indicator in primary breast carcinoma. Int J Cancer 55:371-374, 1993
24. Van Hoef ME, Knox WF, Dhesi SS, et al: Assessment of tumour vascularity as a prognostic factor in lymph node negative invasive breast cancer. Eur J Cancer 29A: 1141-1145, 1993
25. Visscher DW, Smilanetz S, Drozdowicz S, et al: Prognostic significance of image morphometric microvessel enumeration in breast carcinoma. Anal Quant Cytol Histol 15:88-92, 1993
26. Black MM, Opler SR, Speer FI: Survival in breast cancer cases in relation to the structure of the primary tumor and the regional lymph node. Surg Gynecol Obstet 100:543-551, 1955
27. Thor AD, Koemer FC, Edgerton SM, et al: pS2 expression in primary breast carcinomas: relationship to clinical and histological features and survival. Breast Cancer Res Treat 21:111-119,1992
28. Thor A, Benz CC, Moore DH 2d, et al: Stress response protein (srp-27) determination in primary human breast carcinomas: clinical, histologic, and prognostic correlations [see comment citation in Medline]. J Natl Cancer Inst 83:170-178,1991
29. Eng Tan P, Benz CC, Dollbaum C, et al: Prognostic value of cathepsin D expression in breast cancer: immunohistochemical assessment and correlation with radiometric assay. Ann Oncol 5:329-336, 1994.
30. Rae G: On measuring agreement among several judges on the presence or absence of a trait. Educ Psychol Meas 44:247-253,1984.
31. Harrington DP, Fleming TR: A class of rank test procedures for censored survival data. Biometrika 69:553-566,1982
32. Kaplan EL, Meier P: Nonparametric estimation for incomplete observations. J Am Stat Assoc 53:457-481, 1958.
33. Cox DR: Regression models and life tables. J R Stat Soc B 34:187-220, 1972
34. Schoenfeld DA: Partial residuals for the proportional hazards regression model. Biometrika 69:239-241,1982
35. Thomas DC, Siemiatycki J, Dewar R, et al: The problem of multiple inference in studies designed to generate hypotheses. Am J Epidemiol 122:1080-1095,1985
36. McGuire WL, Tandon AK, Allred DC, et al: How to use prognostic factors in axillary node-negative breast cancer patients [see comment citation in Medline], J Natl Cancer Inst 82:1006-1015,1990
37. Simon R, Altman EX: Statistical aspects of prognostic factor studies in oncology [editorial], Br J Cancer 69:979-985,1994
38. Simon RM: Design and conduct of clinical trials. In Cancer: Principles and Practice of Oncology (DeVita VT Jr, Heilman S, Rosenberg SA, eds). Philadelphia: Lippincott, 1989, pp 396-420
39. Rosen PP: The pathology of invasive breast carcinoma. In Breast Diseases (Harris JR, Heilman S, Henderson IC, et al, eds). Philadelphia: Lippincott, 1991, pp 245-296
40. Thor AD, Yandell DW: Prognostic significance of p53 overexpression in node-negative breast carcinoma: preliminary studies support cautious optimism [editorial] [see comment citation in Medline]. J Natl Cancer hist85:176-177,1993
41. Schoenfeld DA: Sample-size formula for the proportional-hazards regression model. Biometrics 39:499-503, 1983